Active, not recruitingPhase 2NCT05831176
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
Studying Eosinophilic gastroenteritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Regeneron Pharmaceuticals
- Principal Investigator
- Clinical Trial ManagementRegeneron Pharmaceuticals
- Intervention
- Dupilumab(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2023 – 2026
Study locations (30)
- Phoenix Childrens Hospital, Phoenix, Arizona, United States
- Om Research LLC, Apple Valley, California, United States
- Scripps Clinic, La Jolla, California, United States
- Om Research LLC, Lancaster, California, United States
- University of California - Los Angeles (UCLA), Los Angeles, California, United States
- University of Southern California Keck School of Medicine, Los Angeles, California, United States
- GastroIntestinal BioSciences, Los Angeles, California, United States
- United Medical Doctors, Murrieta, California, United States
- Ucsf Medical Center (Benioff Childrens Hospital), San Francisco, California, United States
- University of Colorado Anschutz Health Science Building (AHSB) CU Research Pharmacy, Aurora, Colorado, United States
- Connecticut Clinical Research Institute, Bristol, Connecticut, United States
- UConn Health, Farmington, Connecticut, United States
- Encore Borland-Groover Clinical Research, Jacksonville, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- University Of Kansas, Kansas City, Kansas, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Sanofi
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05831176 on ClinicalTrials.govOther trials for Eosinophilic gastroenteritis
Additional recruiting or active studies for the same condition.